Cara De Galan
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent - Cara.DeGalan@UGent.be
- ORCID iD
-
0000-0002-3704-028X
Show
Sort by
-
The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients : a real-life multicentric cohort study
-
New insights in the use of vedolizumab in inflammatory bowel disease
(2022) -
- Journal Article
- A1
- open access
Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study
-
Safety of vedolizumab and ustekinumab in elderly IBD patients : a real-life multicentric cohort study
(2021) UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. In United European Gastroenterology Journal 9(S1). p.554-555 -
- Journal Article
- A1
- open access
Long-term environmental hypoxia exposure and haematopoietic prolyl hydroxylase-1 deletion do not impact experimental Crohn's like ileitis
-
The impact of vedolizumab and ustekinumab on arthropathy and arthralgia in IBD patients : a real-life multicentric cohort study
-
Long-term environmental hypoxia does not impact experimental Crohn's like ileitis
-
Early prediction of response to vedolizumab in patients with active inflammatory bowel disease : a prospective real-life multicentre cohort study
-
Integrin expression changes on the T cells subsets influence the response to vedolizumab in inflammatory bowel disease patients
-
Integrin expression changes on the T cell subsets influence the response to vedolizumab in inflammatory bowel disease patients